Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Toshihiro Nukiwa, Terufumi Katoh et al.|Lung Cancer|2017Cited by 9
P89.06 Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung CancerShingo Matsumoto, Kōichi Goto, Takaya Ikeda et al.|Journal of Thoracic Oncology|2021Cited by 7
Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001Makoto Maemondo, Kana Watanabe, Yukihiro Toi et al.|Translational Lung Cancer Research|2021Cited by 6
The efficacy of immune checkpoint inhibitors and PD-L1 status in patients with advanced non-small cell lung cancer harboring oncogenic driver alterations: Immuno-oncology biomarker study in LC-SCRUM-Japan.Kiyotaka Yoh, Kōichi Goto, Shingo Matsumoto et al.|Journal of Clinical Oncology|2019Cited by 5